That hardly seems based on any fact. Sure, sometimes it is difficult to interpret FDA decisions, but when you methodically work through and improves upon the reasons outlined in the first complete response letter, you strengthen your case immensely.
ALXA has not only done this, but also raised enough capital to support operations through PDUFA.
Any investment is a gamble, but when you look at the facts, and not just generalize like you do, you see that ALXA is a good bet.
Market Data 
Markets 
AI
